The use of analgesics and anti-inflammatories in an oral surgery service in Medellín, Colombia, 2013-2015
DOI:
https://doi.org/10.17533/udea.rfo.v30n2a3Keywords:
Analgesics, Anti-inflammatory drugs, Medical prescriptions, Oral surgical proceduresAbstract
Introduction: dental surgical procedures trigger an inflammatory response, for which dental practitioners prescribe analgesic and anti-inflammatory medications using pharmacological guidelines that require knowledge on the use of medicines in a given environment. The aim of the present study was to identify the analgesics and anti-inflammatory drugs most commonly prescribed at the oral surgery service of the Universidad de Antioquia School of Dentistry. Methods: this retrospective descriptive study reviewed the clinical records of the oral surgery service in the period January 2013-August 2015. A total of 1,177 records were reviewed, and 709 were selected for analysis. Results: 53.1% of the drugs prescribed were non-selective Nonsteroidal Anti-Inflammatory Drugs (NSAIDs). Ibuprofen was formulated in 26.7% of all cases, followed by nimesulide with 24.1% and the combination of acetaminophen plus meloxicam with 10.2%. This same prescription pattern was observed in patients reporting no additional relevant medical history. In the case of gastric history, nimesulide was the drug of choice. 84% of all procedures were surgical extractions of third molars, with ibuprofen 600 mg postoperative for three days as the main therapeutic scheme. Conclusion: ibuprofen, nimesulide, and the combination acetaminophen plus meloxicam were the main analgesics and anti-inflammatory drugs prescribed in this study, according to medical and surgical records.
Downloads
References
Kumar V, Abbas AK, Aster JC. Inflamación y reparación. In: Kumar V, Abbas AK, Aster JC. Robbins. Patología humana. 9th ed. Barcelona: Elsevier; 2013. pp. 29-73
Thomas MV, Puleo DA. Infection, inflammation, and bone regeneration: a paradoxical relationship. J Dent Res 2011; 90(9): 1052-61.DOI: https://doi.org/10.1177/0022034510393967
Kawahara K, Hohjoh H, Inazumi T, Tsuchiya S, Sugimoto Y. Prostaglandin E2-induced inflammation: relevance of prostaglandin E receptors. Biochim Biophys Acta. 2015; 1851(4): 414-21. DOI: https://doi.org/10.1016/j.bbalip.2014.07.008
Herrera-Briones FJ, Prados Sánchez E, Reyes Botella C, Vallecillo Capilla M. Update on the use of corticosteroids in third molar surgery: systematic review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013; 116(5): e342-51. DOI: https://doi.org/10.1016/j.oooo.2012.02.027
Kim K, Brar P, Jakubowski J, Kaltman S, Lopez E. The use of corticosteroids and nonsteroidal antiinflammatory medication for the management of pain and inflammation after third molar surgery: a review
of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009; 107(5): 630-40. DOI: https://doi.org/10.1016/j.tripleo.2008.11.005
Ong CKS, Seymour R A. Pathogenesis of postoperative oral surgical pain. Anesth Prog. 2003; 50(1): 5-17.
Cicconetti A, Bartoli A, Ripari F, Ripari A. Cox-2 selective inhibitors: a literature review of analgesic efficacy and safety in oral-maxillofacial surgery. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004; 97(2): 139-46. DOI: https://doi.org/ 10.1016/S1079210403005985
Pérez RG, Guedes PP, Vives R, Canto G. Antinflamatorios inhibidores selectivos de la cicloxigenasa. Alergol Inmunol Clin. 2002; 17(5): 247-54
Hawkey CJ. COX-1 and COX-2 inhibitors. Best Pract Res Clin Gastroenterol. 2001; 15(5): 801-820. DOI: https://doi.org/10.1053/bega.2001.0236
Capone ML, Tacconelli S, Di Francesco L, Sacchetti A, Sciulli MG, Patrignani P. Pharmacodynamic of cyclooxygenase inhibitors in humans. Prostaglandins Other Lipid Mediat. 2007; 82(1-4): 85-94. DOI: https://doi.org/10.1016/j.prostaglandins.2006.05.019
Harris RC, Breyer MD. Update on Cyclooxygenase-2 inhibitors. Clin J Am Soc Nephrol. 2006; 1(2): 236- 45. DOI: https://doi.org/10.2215/CJN.00890805
Arikawa T, Omura K, Morita I. Regulation of bone morphogenetic protein-2 expression by endogenous prostaglandin E2 in human mesenchymal stem cells. J Cell Physiol. 2004; 200(3): 400-6. DOI: https://doi.org/10.1002/jcp.20031
Fu J-H, Bashutski JD, Al-Hezaimi K, Wang H-L. Statins, glucocorticoids, and nonsteroidal anti-inflammatory drugs. Implant Dent. 2012; 21(5): 362-7. DOI: https://doi.org/10.1097/ID.0b013e3182611ff6
Wang AS, Armstrong EJ, Armstrong AW. Corticosteroids and wound healing: clinical considerations in the perioperative period. Am J Surg. 2013; 206(3): 410-7. DOI: https://doi.org/10.101/j.amjsurg.2012.11.018
Poetker DM, Reh DD. A comprehensive review of the adverse effects of systemic corticosteroids. Otolaryngol Clin North Am. 2010; 43(4): 753-68. DOI: https://doi.org/10.1016/j.otc.2010.04.003
Ong CKS, Seymour RA. An evidence-based update of the use of analgesics in dentistry. Periodontol 2000. 2008; 46(1): 143-64. DOI: https://doi.org/10.1111/j.1600-0757.2008.00225.x
Vonkeman HE, van de Laar MAFJ. Nonsteroidal anti-inflammatory drugs: adverse effects and their prevention. Semin Arthritis Rheum. 2010; 39(4): 294-312. DOI: https://doi.org/10.1016/j.semarthrit.2008.08.001
Asmat AS, Armas LA. Trabajo de Investigación. Eficacia analgésica de paracetamol y naproxeno sódico post exodoncia simple: ensayo clínico aleatorizado y simple ciego. Rev Dent Chile. 2012; 103(3): 18-22
Pérez H. Farmacología y terapéutica odontológica. 2nd ed. Bogotá: Editorial Médica Celsus; 2005
Crawford FIJ, Armstrong D, Boardman C, Coulthard P. Reducing postoperative pain by changing the process. Br J Oral Maxillofac. Surg. 2011; 49(6): 459-63. DOI: https://doi.org/10.101/j.bjoms.2010.07.012
Arnau JM, Laporte JR. Promoción del uso racional de los medicamentos y preparación de guías farmacológicas. In: Laporte JR, Tognoni G. Principios de epidemiología del medicamento. 2nd ed. Barcelona: Masson-Salvat Medicina; 1993. pp. 49-66
Flores, JM; Ochoa, MG; Romero, JJ; Barraza H. Analgésicos en odontología: resultados de una encuesta sobre su uso clínico. Rev ADM. 2014; 71(4): 171-7
Bailey E, Patel N, Coulthard P. Non-steroidal anti-inflammatory drugs for pain after oral surgery. Oral Surg. 2014; 7(3): 152-61. DOI: https://doi.org/10.1111/ors.12073
Hargreaves K, Abbott P V. Drugs for pain management in dentistry. Aust Dent J. 2005; 50(4 Suppl 2): S14-22. DOI: https://doi.org/10.1111/j.1834-7819.2005.tb00378.x
Haas DA. An update on analgesics for the management of acute postoperative dental pain. J Can Dent Assoc. 2002; 68(8): 476-82.
Krenzelok E. The FDA acetaminophen advisory committee meeting – what is the future of acetaminophen in the United States? The perspective of a committee member. Clin Toxicology (Phila). 2009; 47(8): 784-89. DOI: https://doi.org/10.1080/15563650903232345
Alexander RE, Throndson RR. A review of perioperative corticosteroid use in dentoalveolar surgery. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000; 90(4): 406-15. DOI: https://doi.org/10.1067/moe.2000.109778
Macleod AG, Ashford B, Voltz M, Williams B, Cramond T, Gorta L et al. Paracetamol versus paracetamolcodeine in the treatment of post-operative dental pain: a randomized, double-blind, prospective trial. Aust
Dent J. 2002; 47(2): 147-51. DOI: https://doi.org/10.1111/j.1834-7819.2002.tb00319.x
Al-Khateeb TH, Alnahar A. Pain experience after simple tooth extraction. J Oral Maxillofac Surg. 2008; 66(5): 911-17. DOI: https://doi.org/10.1016/j.joms.2007.12.008
Deshpande A, Bhargava D, Gupta M. Analgesic efficacy of acetaminophen for controlling postextraction dental pain. Ann Maxillofac Surg. 2014; 4(2): 176-77. DOI: https://doi.org/10.4103/2231-0746.147117
Colorado-Bonnin M, Valmaseda-Castellón E, Berini-Aytés L, Gay-Escoda C. Quality of life following lower third molar removal. Int J Oral Maxillofac Surg. 2006; 35(4): 343-7. DOI: https://doi.org/10.1016/j.
ijom.2005.08.008
Mehra P, Reebye U, Nadershah M, Cottrell D. Efficacy of anti-inflammatory drugs in third molar surgery: a
randomized clinical trial. Int J Oral Maxillofac Surg. 2013; 42(7): 835-42. DOI: https://doi.org/10.1016/j.
ijom.2013.02.017
Moraschini V, Hidalgo R, Porto Barboza E. Effect of submucosal injection of dexamethasone after third molar surgery: a meta-analysis of randomized controlled trials. Int J Oral Maxillofac Surg 2016; 45(2): 232-40. DOI: https://doi.org/10.1016/j.ijom.2015.09.008
De Menezes SAF, Cury PR. Efficacy of nimesulide versus meloxicam in the control of pain, swelling and trismus following extraction of impacted lower third molar. Int J Oral Maxillofac Surg. 2010; 39(6): 580-84. DOI: https://doi.org/10.1016/j.ijom.2010.03.012
Donati M, Conforti A, Lenti MC, Capuano A, Bortolami O, Motola D et al. Risk of acute and serious liver injury associated to nimesulide and other NSAIDs: data from drug-induced liver injury case-control study in Italy. Br J Clin Pharmacol. 2016; 82(1): 238-48. DOI: https://doi.org/10.1111/bcp.12938
FIMEA FMA. The sale of Nimed, an anti-inflammatory analgesic, is temporarily suspended due to its adverse liver effects [Internet]. Available in: https://www.fimea.fi/web/en/-/the-sale-of-nimed-an-anti-inflammatoryanalgesic-is-temporarily-suspended-due-to-its-adverse-liver-effects
AEMPS AE de M y PS. Comunicación sobre riesgos de medicamentos. Ref: 2002/03. Nota Informativa Nimesulida (Guaxan®, Antifloxil®): suspensión cautelar de comercialización [Internet]. Available in: https://
www.sefh.es/alertas/nimesulida.htm
Traversa G, Bianchi C, Da Cas R, Abraha I, Menniti-Ippolito F, Venegoni M. Cohort study of hepatotoxicity associated with nimesulide and other non-steroidal anti-inflammatory drugs. BMJ. 2003; 327(7405): 18-22.
DOI: https://doi.org/10.1136/bmj.327.7405.18
EMEA EA for the E of MP. Committee for Proprietary Medicinal Products (CPMP) opinion following an article 31 referral. Nimesulide containing medicinal products [Internet]. Available in: http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Nimesulide_31/WC500013818.pdf
INVIMA. Información para profesionales de la salud. Dirección de medicamentos y productos biológico. Grupo de programas especiales-farmacovigilancia. Nimesulide [Internet]. Available in: https://www.
invima.gov.co/images/pdf/farmacovigilancia_alertas/info-seguridad/
Cholongitas E, Koulenti D, Petraki K, Papatheodoridis GV. Nimesulide-induced acute hepatitis. Ann Gastroentol Hepatol. 2003; 16(4): 359-62
Vieira AS, Beijamini V, Melchiors AC. The effect of isotretinoin on triglycerides and liver aminotransferases. An Bras Dermatol. 2012; 87(3): 382-87. DOI: http://dx.doi.org/10.1590/S0365-05962012000300005
Aznar-Arasa L, Harutunian K, Figueiredo R, Valmaseda-Castellón E, Gay-Escoda C. Effect of preoperative ibuprofen on pain and swelling after lower third molar removal: a randomized controlled trial. Int J Oral Maxillofac Surg. 2012; 41(8): 1005-9. DOI: https://doi.org/10.1016/j.ijom.2011.12.028
Graziani F, D’Aiuto F, Arduino PG, Tonelli M, Gabriele M. Perioperative dexamethasone reduces postsurgical sequelae of wisdom tooth removal. A split-mouth randomized double-masked clinical trial. Int J Oral Maxillofac Surg. 2006; 35(3): 241-46. DOI: https://doi.org/10.1016/j.ijom.2005.07.010
Majid OW, Mahmood WK. Effect of submucosal and intramuscular dexamethasone on postoperative sequelae after third molar surgery: comparative study. Br J Oral Maxillofac Surg. 2011; 49(8): 647-52. DOI:
https://doi.org/10.1016/j.bjoms.2010.09.021
Galofré JC. Manejo de los corticoides en la práctica clínica. Rev Med Univ Navarra. 2009; 53(1): 9-18.
Marshall JG. Consideration of steroids for endodontic pain. Endod Topics. 2002; 3(1): 41-51. DOI: https://doi.org/10.1034/j.1601-1546.2002.30105.x
Schimmer BP, Funder JW. ACTH, esteroides suprarrenales y farmacología de la corteza suprarrenal. in: Brunton LL, Chabner BA, Knollmann BC. Goodman & Gilman: Las bases farmacológicas de la terapéutica. 12th ed. Mexico DF: Mc Graw Hill; 2012. pp. 1209-36
Poveda Roda R, Bagán JV, Jiménez-Soriano Y, Gallud Romero L. Use of nonsteroidal anti-inflammatory drugs in dental practice. A review. Med Oral Patol Oral Cir Bucal. 2007; 12(1): E10-8
Bjørnsson GA, Haanæs HR, Skoglund LA. A randomized, double-blind crossover trial of paracetamol 1000 mg four times daily vs ibuprofen 600 mg: effect on swelling and other postoperative events after
third molar surgery. Br J Clin Pharmacol. 2003; 55(4): 405-12. DOI: https://doi.org/10.1046/j.1365-2125.2003.01779.x
Vega Otiniano AL, Millones Gómez PA. Manejo odontológico de pacientes con tratamiento anticoagulante. Crescendo cienc salud. 2015; 2(2): 523-29
Madhulaxmi M, Abdul Wahab PU. Can aspirin be continued during dental extraction? Int J Pharm Pharm Sci. 2014; 6(1): 20-3
Ardekian L, Gaspar R, Peled M, Brener B, Laufer D. Does low-dose aspirin therapy complicate oral surgical procedures? J Am Dent Assoc. 2000; 131(3): 331-35. DOI: https://doi.org/10.14219/jada.archive.2000.0176
Brennan MT, Wynn RL, Miller CS. Aspirin and bleeding in dentistry: an update and recommendations. Oral Surgery Oral Med Oral Pathol Oral Radiol Endod. 2007; 104(3): 316-23. DOI: https://doi.org/10.1016/j.
tripleo.2007.03.003
Moore PA, Hersh EV. Combining ibuprofen and acetaminophen for acute pain management after third-molar extractions. J Am Dent Assoc. 2013; 144(8): 898-908. DOI: https://doi.org/10.14219/jada.archive.2013.0207
Mehlisch DR, Aspley S, Daniels SE, Southerden KA, Christensen KS. A single-tablet fixed-dose combination of racemic ibuprofen/paracetamol in the management of moderate to severe postoperative dental pain in adult and adolescent patients: a multicenter, two-stage, randomized, double-blind, parallelgroup, placebo-control, factorial study. Clin Ther. 2010; 32(6): 1033-49. DOI: https://doi.org/10.1016/j.clinthera.2010.06.002
Bailey E, Worthington H, Coulthard P. Ibuprofen and/or paracetamol (acetaminophen) for pain relief after surgical removal of lower wisdom teeth, a Cochrane systematic review. Br Dent J. 2014; 216(8): 451-55.
DOI: https://doi.org/10.1038/sj.bdj.2014.330
Barden J, Edwards JE, McQuay HJ, Moore RA. Pain and analgesic response after third molar extraction and other postsurgical pain. Pain. 2004; 107(1-2): 86-90. DOI: https://doi.org/10.1016/j.pain.2003.09.021
Morales DR, Lipworth BJ, Guthrie B, Jackson C, Donnan PT, Santiago VH. Safety risks for patients with aspirin-exacerbated respiratory disease after acute exposure to selective nonsteroidal anti-inflammatory drugs and COX-2 inhibitors: meta-analysis of controlled clinical trials. J Allergy Clin Immunol. 2014; 134(1): 40-45. DOI: https://doi.org/10.1016/j.jaci.2013.10.057
Downloads
Additional Files
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2019 Revista Facultad de Odontología Universidad de Antioquia
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright Notice
Copyright comprises moral and patrimonial rights.
1. Moral rights: are born at the moment of the creation of the work, without the need to register it. They belong to the author in a personal and unrelinquishable manner; also, they are imprescriptible, unalienable and non negotiable. Moral rights are the right to paternity of the work, the right to integrity of the work, the right to maintain the work unedited or to publish it under a pseudonym or anonymously, the right to modify the work, the right to repent and, the right to be mentioned, in accordance with the definitions established in article 40 of Intellectual property bylaws of the Universidad (RECTORAL RESOLUTION 21231 of 2005).
2. Patrimonial rights: they consist of the capacity of financially dispose and benefit from the work trough any mean. Also, the patrimonial rights are relinquishable, attachable, prescriptive, temporary and transmissible, and they are caused with the publication or divulgation of the work. To the effect of publication of articles in the journal Revista de la Facultad de Odontología, it is understood that Universidad de Antioquia is the owner of the patrimonial rights of the contents of the publication.
The content of the publications is the exclusive responsibility of the authors. Neither the printing press, nor the editors, nor the Editorial Board will be responsible for the use of the information contained in the articles.
I, we, the author(s), and through me (us), the Entity for which I, am (are) working, hereby transfer in a total and definitive manner and without any limitation, to the Revista Facultad de Odontología Universidad de Antioquia, the patrimonial rights corresponding to the article presented for physical and digital publication. I also declare that neither this article, nor part of it has been published in another journal.
Open Access Policy
The articles published in our Journal are fully open access, as we consider that providing the public with free access to research contributes to a greater global exchange of knowledge.
Creative Commons License
The Journal offers its content to third parties without any kind of economic compensation or embargo on the articles. Articles are published under the terms of a Creative Commons license, known as Attribution – NonCommercial – Share Alike (BY-NC-SA), which permits use, distribution and reproduction in any medium, provided that the original work is properly cited and that the new productions are licensed under the same conditions.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
